Breaking News

  • 2 days ago

  • Simantini Singh Deo

Commit Biologics Appoints Thomas L. F. Montgomery Andresen, Ph.D., As CEO As Company Prepares To Enter Clinical Development Following €21.5M Seed Backing From Novo Holdings
Breaking News

More News

Clearmind Medicine Begins Enrollment For Third Cohort In FDA-Approved Phase I/IIa Trial Of Non-Hallucinogenic AUD Treatment CMND-100

Clearmind Medicine Begins Enrollment For Third Cohort In FDA-Approved ...

Simantini Singh Deo

Ad
Advertisement

Upcoming Pharma Events

Events

Feb 14 - Event - 2026

Indian Pharma Cricket League 2026

Venue - India

Events

Mar 22 - Conference - 2026

Pharma Forum 2026

Venue - Boston

Events

Mar 24 - Exhibition / Trade Show - 2026

analytica 2026

Venue - Germany

Events

Mar 29 - Exhibition / Trade Show - 2026

Asia Pharma Expo 2026

Venue - Dhaka

Events

Mar 31 - Conference - 2026

PharmaXcelerate - Building Resilient Pharma, Biotech Facilities & Quality Systems

Venue - Dubai, UAE

Mar

22

Conference - 2026

PDA Week 2026

Venue - Denver, USA

Mar

25

Conference - 2026

15th Pharma Packaging & Labeling Innovation Forum 2026

Venue - Boston

Apr

15

Conference - 2026

Digital Labs Summit Europe 2026

Venue - Berlin, Germany

May

11

Conference - 2026

TIDES USA 2026

Venue - Boston

Ad
Advertisement
Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox

Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox

Ad
Advertisement

Knowledge Hub

Research

ResearchPROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug DiscoveryNeuroinflammation As A Target Class: The New Frontier In CNS Drug DevelopmentSenolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing